This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Jan;117(2):137-42.

doi: 10.1111/j.1471-0528.2009.02369.x.

Cervical cancer: problem solved? Vaccinating girls against human papillomavirus

E J Crosbie¹, L Brabin

Affiliations

PMID: 20050177
DOI: 10.1111/j.1471-0528.2009.02369.x

Cervical cancer: problem solved? Vaccinating girls against human papillomavirus

E J Crosbie et al. BJOG. 2010 Jan.

. 2010 Jan;117(2):137-42.

doi: 10.1111/j.1471-0528.2009.02369.x.

Authors

E J Crosbie¹, L Brabin

Affiliation

¹ School of Cancer and Imaging Science, University of Manchester, Manchester, UK. emma.crosbie@manchester.ac.uk

PMID: 20050177
DOI: 10.1111/j.1471-0528.2009.02369.x

No abstract available

PubMed Disclaimer

Similar articles

Fewer shots proposed to increase uptake of HPV vaccine.
Dorans K. Dorans K. Nat Med. 2010 Aug;16(8):832-3. doi: 10.1038/nm0810-832b. Nat Med. 2010. PMID: 20689528 No abstract available.
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.
Van de Velde N, Boily MC, Drolet M, Franco EL, Mayrand MH, Kliewer EV, Coutlée F, Laprise JF, Malagón T, Brisson M. Van de Velde N, et al. J Natl Cancer Inst. 2012 Nov 21;104(22):1712-23. doi: 10.1093/jnci/djs395. Epub 2012 Oct 27. J Natl Cancer Inst. 2012. PMID: 23104323
Effectiveness of the quadrivalent human papillomavirus vaccine against cervical dysplasia in Manitoba, Canada.
Mahmud SM, Kliewer EV, Lambert P, Bozat-Emre S, Demers AA. Mahmud SM, et al. J Clin Oncol. 2014 Feb 10;32(5):438-43. doi: 10.1200/JCO.2013.52.4645. Epub 2014 Jan 6. J Clin Oncol. 2014. PMID: 24395857
An update on barriers to adolescent human papillomavirus vaccination in the USA.
Berenson AB. Berenson AB. Expert Rev Vaccines. 2015;14(10):1377-84. doi: 10.1586/14760584.2015.1078240. Epub 2015 Aug 13. Expert Rev Vaccines. 2015. PMID: 26292763 Review.
[Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
Friedek DA, Ekiel AM, Martirosian G. Friedek DA, et al. Wiad Lek. 2007;60(1-2):34-8. Wiad Lek. 2007. PMID: 17607966 Review. Polish.

See all similar articles

Cited by

HPV Vaccination and Testing.
Kent A. Kent A. Rev Obstet Gynecol. 2010 Winter;3(1):33-4. Rev Obstet Gynecol. 2010. PMID: 20508781 Free PMC article. No abstract available.
Feasibility of delivering HPV vaccine to girls aged 10 to 15 years in Uganda.
Mugisha E, LaMontagne DS, Katahoire AR, Murokora D, Kumakech E, Seruyange R, Tsu VD. Mugisha E, et al. Afr Health Sci. 2015 Mar;15(1):33-41. doi: 10.4314/ahs.v15i1.5. Afr Health Sci. 2015. PMID: 25834528 Free PMC article.
Global challenges of implementing human papillomavirus vaccines.
Graham JE, Mishra A. Graham JE, et al. Int J Equity Health. 2011 Jun 30;10:27. doi: 10.1186/1475-9276-10-27. Int J Equity Health. 2011. PMID: 21718495 Free PMC article.
Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women.
Zimet GD, Weiss TW, Rosenthal SL, Good MB, Vichnin MD. Zimet GD, et al. BMC Womens Health. 2010 Sep 1;10:27. doi: 10.1186/1472-6874-10-27. BMC Womens Health. 2010. PMID: 20809965 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information